Patent Assignment
Reel/Frame 012729/0012
Assignment of Assignor's Interest
Recorded: 2002-03-26
Pages: 3
Assignor
HOECHST AKTIENGESELLSCHAFT (HOECHST AG)
Executed: 2002-03-04
Assignee
AVENTIS PHARMA DEUTSCHLAND GMBH (AVENTIS PHARMA)
INDUSTRIEPARK HOCHST - GEBAUDE K 801, 65926 FRANKFURT AM MAIN, GERMANY
Covered Property
(1)
Usle of a Combination of Angiotensin-Converting Enzyme Inhibitor and Calcium Antagonist for the Treatment of Proteinuria
Patent:
5,236,933 →
Application:
07/798,501 →
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignors Interest.
Nov 26, 1991
From: BECKER, REINHARD; HENNING, RAINER; TEETZ, VOLKER; URBACH, HANSJORG
To: HOECHST AKTIENGESELLSCHAFT A CORP. OF THE FEDERAL REPUBLIC OF GERMANY
Reel/Frame 005929/0952 →
Supplement to Security Agreement
Mar 11, 1999
From: KING PHARMACEUTICALS, INC.
To: CREDIT SUISSE FIRST BOSTON
Reel/Frame 009808/0528 →
Change of Name
Aug 18, 2000
From: HOECHST MARION ROUSSEL DEUTSCHLAND GMBH
To: AVENTIS PHARMA DEUTSCHLAND GMBH
Reel/Frame 011019/0234 →
Change of Name
Nov 18, 2005
From: AVENTIS PHARMA DEUTSCHLAND GMBH
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 016793/0789 →
Release of Security Interest
Feb 3, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 025741/0564 →
Release of Security Interest
Feb 4, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS, INC.
Reel/Frame 025746/0793 →